Back to Search Start Over

MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma.

Authors :
Zhang W
Li GS
Gan XY
Huang ZG
He RQ
Huang H
Li DM
Tang YL
Tang D
Zou W
Liu J
Dang YW
Chen G
Zhou HF
Kong JL
Lu HP
Source :
PeerJ [PeerJ] 2023 Aug 16; Vol. 11, pp. e15598. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: Worldwide, lung squamous cell carcinoma (LUSC) has wreaked havoc on humanity. Matrix metallopeptidase 12 ( MMP12 ) plays an essential role in a variety of cancers. This study aimed to reveal the expression, clinical significance, and potential molecular mechanisms of MMP12 in LUSC.<br />Methods: There were 2,738 messenger RNA (mRNA) samples from several multicenter databases used to detect MMP12 expression in LUSC, and 125 tissue samples were validated by immunohistochemistry (IHC) experiments. Receiver operator characteristic (ROC) curves, Kaplan-Meier curves, and univariate and multivariate Cox regression analyses were used to assess the clinical value of MMP12 in LUSC. The potential molecular mechanisms of MMP12 were explored by gene enrichment analysis and immune correlation analysis. Furthermore, single-cell sequencing was used to determine the distribution of MMP12 in multiple tumor microenvironment cells.<br />Results: MMP12 was significantly overexpressed at the mRNA level ( p  < 0.05, SMD = 3.13, 95% CI [2.51-3.75]), which was verified at the protein level ( p  < 0.001) by internal IHC experiments. MMP12 expression could be used to differentiate LUSC samples from normal samples, and overexpression of MMP12 itself implied a worse clinical prognosis and higher levels of immune cell infiltration in LUSC patients. MMP12 was involved in cancer development and progression through two immune-related signaling pathways. The high expression of MMP12 in LUSC might act as an antigen-presenting cell-associated tumor neoantigen and activate the body's immune response.<br />Conclusions: MMP12 expression is upregulated in LUSC and high expression of MMP12 serves as a risk factor for LUSC patients. MMP12 may be involved in cancer development by participating in immune-related signaling pathways and elevating the level of immune cell infiltration.<br />Competing Interests: Gang Chen is an Academic Editor for PeerJ.<br /> (©2023 Zhang et al.)

Details

Language :
English
ISSN :
2167-8359
Volume :
11
Database :
MEDLINE
Journal :
PeerJ
Publication Type :
Academic Journal
Accession number :
37601247
Full Text :
https://doi.org/10.7717/peerj.15598